Advertisement
Advertisement

MNKD

MNKD logo

Mannkind Corporation

4.11
USD
Sponsored
+0.22
+5.66%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

4.08

-0.03
-0.71%

Mannkind Corporation Profile

About

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

Info & Links

CEO

Michael E. Castagna

Headquarters

1 CASPER STREET
DANBURY, CT 06810, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.mannkindcorp.com

Auditor

Deloitte & Touche LLP

Share holders

90

Employees

592

Mannkind Corporation Statistics

Valuation Measures

Market Capitalization2

1.31B

Enterprise Value

1.68B

Enterprise Value/EBITDA(ttm)

53.43

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

3.23

Price to Book(mrq)

--

Price to Cash(ytd)

66.42

Profitability

Gross Margin(ttm)

75.63%

Operating Margin(ttm)

-11.08%

Profit Margin(ttm)

-10.09%

Return on Equity(ttm)

-11.21%

Return on Invested Capital(ttm)

-8.13%

Return on Assets(ttm)

-6.44%

Income Statement

Revenue(ttm)

393.63M

Revenue Per Share(ttm)

1.22

Gross Profit(ttm)

296.74M

EBITDA(ttm)3

31.47M

Net Income Available to Common(ttm)

-43.61M

Diluted EPS(ttm)

-0.13

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

19.83%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

321.54M

Dividend Yield

0.00%

Float4

300.92M

% Held by Insiders

2.60%

% Held by Institutions

49.55%

Balance Sheet

Total Cash(mrq)

111.13M

Total Cash Per Share(mrq)

0.35

Total Debt(mrq)

422.07M

Total Debt/Equity(mrq)

-628.11%

Current Ratio(mrq)

1.72%

Quick Ratio(mrq)

1.50%

Book Value Per Share(mrq)

-0.22

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.08

Free Cash Flow(ytd)

-30.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement